News
News

The latest updates from AFAR.

Board Member in the News: S. Jay Olshansky on Retirement Age Study in US News & World Reports

Sep 29
2015

Board Member in the News: S. Jay Olshansky on Retirement Age Study in US News & World Reports

On September 24, 2015 US News & World Reports, picked up a story originally published on HealthDay.com, featuring comments by Board Member S. Jay Olshansky, PhD, on a new studying look at the effects staying in the workplace longer has on the health of older adults. While the study found that adults who remained in the workplace after 65 remained healthier than their retired or unemployed peers, Dr. Olshansky cautioned that does not necessary prove that working keeps people healthy.  He did however feel that forcing individuals out of the workplace after a certain age could have negative effects, stating, "We…


View MoreREAD MORE


Grantee in the News: COE Investigators Cited In NYT Opinion Piece on the Geriatrician Shortage

Sep 25
2015

Grantee in the News: COE Investigators Cited In NYT Opinion Piece on the Geriatrician Shortage

On September 22nd, two Center of Excellence investigators, Rosanne Leipzig, MD, PhD, and David Reuben, MD, were featured in The New York Times Opinion Pages in a piece highlighting the geriatrician shortage. While older adults who are monitored by a geriatrician enjoy more years of independent living, greater social and physical functioning and lower presence of disease, there are currently fewer 8,000 geriatrician’s nationwide, the piece article notes.Dr. Leipzig refers to geriatricians as an “endangered species” and Dr. Reuben worries that the shortage could result in a national crisis as the population continues to…


View MoreREAD MORE


AFAR in the News: Science magazine spotlights AFAR investigators and TAME Trial

Sep 18
2015

AFAR in the News: Science magazine spotlights AFAR investigators and TAME Trial

On September 16th, 2015, Science magazine published a feature on Deputy Scientific Director Nir Barzilai and the momentum of on the AFAR-supported Taming Aging with Metformin (TAME) clinical trial. Also featuring AFAR Scientific Director Steven Austad, PhD; and Board Members James Kirkland, MD, PhD; and S. Jay Olshansky, as well as 1993 AFAR Research Grant recipient Felipe Sierra, PhD, the piece highlighted their involvement with designing the first-ever clinical trial focused on the co-mortalities of age related disease. Framed by their recent meeting with the FDA to encourage making aging an indicator to move metformin and other promising drugs into clinical…


View MoreREAD MORE


Grantee in the News: Three-Time Grantee Dena Dubal Profiled in Neurology Today

Sep 17
2015

Grantee in the News: Three-Time Grantee Dena Dubal Profiled in Neurology Today

On September 17, 2015, Neurology Today profiled the professional development and current research of three-time AFAR grantee, Dena Dubal, MD, PhD. The article surveys Dr. Dubal’s research on how the Klotho enzyme effects brain biology as well as her investigation into the biological longevity of the X-chromosome.  Now four years into running her own lab, Dr. Dubal states, “I love leading the science, we don't know where the science will take us. But we ask big questions with the goal of high-impact biomedical discoveries. I really hope that our findings lead to ways in which we…


View MoreREAD MORE


AFAR in the News: Scientific Director Steven Austad in Discover magazine’s “Science vs. Aging” issue

Sep 11
2015

AFAR in the News: Scientific Director Steven Austad in Discover magazine’s “Science vs. Aging” issue

In their  “Science vs Aging” cover story of their October 2015 issue, Discover magazine features several AFAR affiliated experts: Scientific Director, Steven Austad, PhD; 1995 MetLife Foundation Awards for Medical Research recipient, Rudolph Tanzi, PhD; and 1993 AFAR Research Grant recipient, Felipe Sierra, PhD. In this eleven-page spread, our experts are featured across several articles. In the closing article, “The Seven Pillars of Aging,” Dr. Austad and Dr. Sierra lend insights into the core areas that researchers believe will help to propel the field over the next twenty years. Dr. Tanzi’s expertise on Alzheimer&rsquo…


View MoreREAD MORE




BACK TO TOPBACK TO TOP